Maternal serum screening for Down's syndrome on population basis

Acta Obstetricia et Gynecologica Scandinavica

Volumn 76, Issue 9, 1997, Pages 817-821

  Salonen, Riitta ^a,b   Turpeinen, Ursula ^a   Kurki, Laina ^a   Lappalainen, Mari ^a   Ämmälä, Pirkko ^a   Hiilesmaa, Vilho ^a   Teramo, Kari ^a   Von Koskull, Harriet ^a   Gahmberg, Nina ^a   Stenman, Ulf Håkan ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Dept of Obstetrics and Gynaecology   (Finland)

Author keywords

Down's syndrome; Maternal; Prenatal; Screening; Serum

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADULT; AMNIOCENTESIS; ARTICLE; CHORION VILLUS SAMPLING; CHROMOSOME ABERRATION; DOWN SYNDROME; FEMALE; FINLAND; HUMAN; HUMAN EXPERIMENT; MATERNAL AGE; MOSAICISM; PRENATAL SCREENING; PRIORITY JOURNAL; ULTRASOUND;

EID: 9844245892     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016349709024358     Document Type: Article

References (22)

1. Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992; 327: 588-93.
2. Wald NJ, Kennard A, Densem JW, Cuckle HS, Chard T, Butler L. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. Br Med J 1992; 305: 391-4.
3. Herrou M, Leporrier N, Leymarie P. Screening for fetal Down syndrome with maternal serum hCG and oestriol: a prospective study. Prenat Diagn 1992; 12: 887-92.
4. Phillips OP, Elias S, Shulman LP, Andersen RN, Morgan CD, Simpson JL. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated oestriol: a prospective 2-year study. Obstet Gynecol 1992; 80: 353-8.
5. Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickok DE. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated oestriol. Obstet Gynecol 1993; 81: 72-7.
6. Muller F, Aegerter P, Boue A. Prospective maternal serum human chorionic gonadotropin screening for the risk of fetal chromosome anomalies and of subsequent fetal and neonatal deaths. Prenat Diagn 1993; 13: 29-43.
7. Burton BK, Prins GS, Verp MS. A prospective trial of prenatal screening for Down syndrome by means of maternal serum α-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol. Am J Obstet Gynecol 1993; 169: 526-30.
8. Spencer K, Carpenter P. Prospective study of prenatal screening for Down's syndrome with free β human chorionic gonadotrophin. Br Med J 1993; 307: 764-6.
9. Wenstrom KD, Williamson RA, Grant SS, Hudson JD, Getchell JP. Evaluation of multiple-marker screening for Down syndrome in a statewide population. Am J Obstet Gynecol 1993; 169: 793-7.
10. Goodburn SF, Yates JRW, Raggatt PR, Carr C, Ferguson-Smith ME, Kershaw AJ et al. Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme. Prenat Diagn 1994; 14: 391-402.
11. Piggott M, Wilkinson P, Bennett J. Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). J Med Screen 1994; 1: 45-9.
12. Salonen R, Simola K, Harjulehto-Mervaala T, Aro T, Saxen L. Incidence of Down syndrome and prenatal diagnosis during the years 1984-1988 in Finland. Duodecim 1993; 109: 681-6.
13. Salonen R, Kurki L, Lappalainen M. Experiences of mothers participating in maternal serum screening for Down's syndrome. Eur J Hum Genet 1996; 4: 113-19.
14. Wald NJ, Cuckle HS, Densem JW, Nachanal K, Royston P, Chard T et al. Maternal serum screening for Down's syndrome in early pregnancy. Br Med J 1988; 297: 883-7.
15. Saller DN, Canick JA, Schwartz S, Blitzer MG. Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome. Am J Obstet Gynecol 1992; 167: 1021-4.
16. Wenstrom KD, Williamson RA, Grant SS. Detection of fetal Turner syndrome with multiple-marker screening. Am J Obstet Gynecol 1994; 170: 570-3.
17. Knowles S, Flett P. Multiple marker screen positivity in the presence of hydrops fetalis. Prenat Diagn 1994; 14: 403-5.
18. Rooney DE, Czepulkowski BH. Tissue culture methods in human cytogenetics. In: Rooney DE, Czepulkowski BH, eds. Human cytogenetics: a practical approach. Oxford: IRL Press Ltd, 1986:1-37.
19. Wenström KD, Owen J, Boots LR, DuBard MB. Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome. Am J Obstet Gynecol 1994; 171: 1038-41.
20. Pergament E, Stein AK, Fiddler M, Cho NH, Kupfermine MJ. Adverse pregnancy outcome after a false-positive screen for Down syndrome using multiple markers. Obstet Gynecol 1995; 86: 255-8.
21. Kalousek DK, Langlois S, Barrett I, Yam I, Wilson DR, Howard Peebles PN et al. Uniparental disomy for chromosome 16 in humans. Am J Hum Genet 1993: 52: 8-16.
22. Wolstenholme J. An audit on trisomy 16 in man. Prenat Diagn 1995; 15: 109-21.